Author

Montserrat Rivero 1

1 Marqués de Valdecilla Universitary Hospital, Gastroenterology Unit, Santander, Spain

EFFECTIVENESS AND SAFETY OF THE SWITCH FROM REMICADE<sup>®</sup> TO CT-P13 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Maria Chaparro Sanchez, A Garre, Maria Fernanda Guerra Veloz, J M Vázquez, M L De Castro, Eduardo Leo Carnerero, E Rodríguez, A Y Carbajo, Sabino Riestra Menéndez, I Jiménez, Xavier Calvet Calvo, Luis Bujanda, Montserrat Rivero, Fernando Gomollón, Jose Manuel Benitez, Fernando Bermejo, Noelia Alcaide, Ana Gutierrez Casbas;

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASES

Maria Chaparro Sanchez, Ana Garre, Elena Ricart, Marisa Iborra, Francisco Mesonero Gismero, Maria Vera, Sabino Riestra Menéndez, V García-Sánchez, Luisa de Castro, A Martin-Cardona, Xavier Aldeguer, M Mínguez, Manuel Barreiro de-Acosta, Montserrat Rivero, F Muñoz, Montserrat Andreu, A Bargallo, E García-Planella, J. L. Pé

EFFICACY AND SAFETY OF THE SEQUENTIAL USE OF A SECOND AND THIRD ANTI-TNF DRUG IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

María José Casanova, Maria Chaparro Sanchez, Miguel Mínguez, Elena Ricart, Carlos Taxonera, Santiago García-López, Jordi Guardiola Capon, Antonio López-San Román, Eva Iglesias, Pilar Nos, Beatriz Sicilia, Maria Isabel Vera, Joaquin Hinojosa, Sabino Riestra, Eugeni Domenech Morral, Xavier Calvet Calvo, José Lázaro Pérez-Call

Epidemiology, clinical characteristics, evolution and treatments in newly diagnosed inflammatory bowel disease (IBD): results from the nationwide EpidemIBD study of GETECCU

Maria Chaparro Sanchez, Manuel Barreiro-de Acosta, Jose Manuel Benitez, Jose Luis Cabriada, María José Casanova, Daniel Ceballos, María Esteve, Hipólito Fernández, Daniel Ginard, Fernando Gomollón, Rufo H. Lorente, Pilar Nos, Sabino Riestra, Montserrat Rivero, Pilar Robledo, Cristina Rodriguez, Beatriz Sicilia, Emilio Torr

EPIDEMIOLOGY, DIAGNOSTIC WORK-UP AND PHARMACOLOGICAL TREATMENTS OF INFLAMMATORY BOWEL DISEASE IN SPAIN: RESULTS FROM THE NATIONWIDE EPIDEMIBD STUDY OF GETECCU

Maria Chaparro Sanchez, Manuel Barreiro de-Acosta, Jose Manuel Benitez, Jose Luis Cabriada Nuño, María José Casanova González, Daniel Ceballos, Maria Esteve Comas, Hipolito Fernández Rosáenz, Daniel Ginard Vicens, Fernando Gomollón Garcia, Rufo Lorente Poyatos, Pilar Nos Mateu, Sabino Riestra Menéndez, Montserrat Rivero, Pila

HOSPITALIZATION RISK AND REINTERVENTION AFTER ILEOCOLONIC RESECTION WITH ANASTOMOSIS IN PATIENTS WITH CROHN'S DISEASE. RESULTS FROM THE PRACTICROHN STUDY

Valle García, Marta Calvo, Maria Dolores Martín Arranz, Montserrat Rivero, Eugeni Domenech Morral, Manuel Barreiro de Acosta, Esther García Planella, Ana Gutierrez Casbas, Cristina Romero, Luis Cea-Calvo, Berta Juliá De Páramo

IMMUNOMODULATOR AND BIOLOGICAL THERAPY ARE INCREASED IN INFLAMATORY BOWEL DISEASE PATIENTS WITH ASSOCIATED IMMUNO-MEDIATED INFLAMMATORY DISEASES

María José García García, Marta Pascual, Carmen Del Pozo, Laura Rasines, Beatriz Castro, Javier Crespo, Montserrat Rivero

Is the switch to a second thiopurine a safe strategy in elderly patients with inflammatory bowel disease? A multicentre cohort study of the ENEIDA registry

Margalida Calafat Sard, Miriam Mañosa, Elena Ricart, Sandra Marín Pedrosa, Marta Calvo, Francisco Rodriguez-Moranta, Carlos Taxonera Samso, Pilar Nos Mateu, Francisco Mesonero, Mariló Martin-Arranz, Miguel Mínguez, Javier Gisbert, Santiago García-López, Ruth De Francisco Garcia, Fernando Gomollón Garcia, Xavier Calvet, Esth

METHOTREXATE AFTER ANTI-TNF-α FAILURE IN CROHN'S DISEASE: A RETROSPECTIVE SERIES FROM THE ENEIDA REGISTRY. TEACHING AN OLD DOG NEW TRICKS?

Francisco Mesonero, Jesus Castro Poceiro, Elena Ricart, Jose Manuel Benitez, Blau Camps Aler, Jordi Guardiola, Marisa Iborra, Alicia López-García, Paola Francesca Torres Rodríguez, María Esteve, Joan Tosca, Federico Bertoletti, Pedro Almela, Xavier Calvet, Maria Isabel Vera, Luis Bujanda, Fernando Gomollón Garcia, Cristina

Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry

Margalida Calafat Sard, Miriam Mañosa, Elena Ricart, Pilar Nos Mateu, Eva Iglesias, Isabel Vera, Antonio López-San Román, Jordi Guardiola, Carlos Taxonera, Miguel Mínguez, Mariló Martin-Arranz, Luisa de Castro, Sabino Riestra, Montserrat Rivero, Esther García-Planella, Xavier Calvet, Santiago García-López, Montserrat Andre

Item 1 - 10 / 16
1
2